HR 2213 · in committee · major
Medical Supply Chain Resiliency Act
- economy
What this bill does
- The bill lets the President negotiate trade agreements with other countries to increase access to medical devices and pharmaceuticals.
- Affected parties include medical device manufacturers, pharmaceutical companies, healthcare providers, and patients relying on imported medical goods.
- The President can modify tariffs and trade rules if they determine it strengthens U.S. national security and public health; Congress can block agreements within 60 days.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How might expanding the President's authority to negotiate medical supply trade agreements affect domestic manufacturers compared to international competitors?
- 02
What criteria should determine when tariff modifications serve national security versus when they primarily benefit specific industries or consumers?
- 03
If Congress has 60 days to block trade agreements, what safeguards would help ensure sufficient time for reviewing complex pharmaceutical and medical device impacts?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-NY-11
Nicole Malliotakis
Citizen cosponsors
0
In Congress
19/ 435
House Reps cosponsoring
Introduced 2025-03-18
Joining the bill
Bradley Scott Schneider
D-IL-10 · original
Jake Auchincloss
D-MA-4
Donald G. Davis
D-NC-1
Mike Kelly
R-PA-16
Carol D. Miller
R-WV-1
Al Green
D-TX-9
Mariannette Miller-Meeks
R-IA-1
Deborah K. Ross
D-NC-2
Thomas R. Suozzi
D-NY-3
Gregory F. Murphy
R-NC-3
Josh Gottheimer
D-NJ-5
Eugene Simon Vindman
D-VA-7
+ 7 more
Legislative timeline
2025-03-18 · house · IntroReferral
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-18 · house · IntroReferral
Referred to the Committee on Ways and Means, and in addition to the Committee on Rules, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-03-18 · IntroReferral
Introduced in House
2025-03-18 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.